Publications for Maria Hjorth
Co-author map based on ISI articles 2007-
Publications mentioned in social media 3 times*
Journal Articles
Stina Axelsson, Maria Hjorth, Johnny Ludvigsson and Rosaura Casas
Decreased GAD(65) -specific Th1/Tc1 phenotype in children with Type 1 diabetes treated with GAD-alum.
Diabetic Medicine, 2012, 29(10), 1272-1278.
Fulltext  |
Stina Axelsson, Mikael Chéramy, Maria Hjorth, Mikael Pihl, Linda Åkerman, Emanuela Martinuzzi, Roberto Mallone, Johnny Ludvigsson and Rosaura Casas
Long-Lasting Immune Responses 4 Years after GAD-Alum Treatment in Children with Type 1 Diabetes
PLoS ONE, 2011, 6(12), .
Fulltext Web of Science® Times Cited: 4 |
Johnny Ludvigsson, Maria Hjorth, Mikael Chéramy, Stina Axelsson, Mikael Pihl, G Forsander, N-O Nilsson, B-O Samuelsson, T Wood, J Aman, E Ortqvist and Rosaura Casas
Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial
DIABETOLOGIA, 2011, 54(3), 634-640.
Fulltext Web of Science® Times Cited: 19 |
Maria Hjorth, Stina Axelsson, Anna Ryden, Maria Faresjo, Johnny Ludvigsson and Rosaura Casas
GAD-alum treatment induces GAD(65)-specific CD4(+)CD25(high)FOXP3(+) cells in type 1 diabetic patients
CLINICAL IMMUNOLOGY, 2011, 138(1), 117-126.
Web of Science® Times Cited: 9 |
Stina Axelsson, Maria Hjorth, Linda Åkerman, Johnny Ludvigsson and Rosaura Casas
Early induction of GAD(65)-reactive Th2 response in type 1 diabetic children treated with alum-formulated GAD(65)
Diabetes/Metabolism Research Reviews, 2010, 26(7), 559-568.
Web of Science® Times Cited: 8 |
Ulf-Henrik Mellqvist, Stig Lenhoff, Hans E. Johnsen, Maria Hjorth, Erik Holmberg, Gunnar Juliusson, Jon Magnus Tangen and Jan Westin
Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma - Results of a randomized comparison with vincristine, doxorubicin,
Cancer, 2008, 112(1), 129-135.
Web of Science® Times Cited: 14 |
Johnny Ludvigsson, Maria Faresjö, Maria Hjorth, Stina Axelsson, Mikael Chéramy, Mikael Pihl, Outi Vaarala, Gun Forsander, Sten Ivarsson, Calle Johansson, Agne Lindh, NO Nilsson, Jan Åman, Eva Örtqvist, Peter Zerhouni and Rosaura Casas
GAD treatment and insulin secretion in recent-onset type 1 diabetes
New England Journal of Medicine, 2008, 359(18), 1909-1920.
|
Maria Hedman Hjorth, Johnny Ludvigsson and Maria Faresjö
Nicotinamide reduces high secretion of IFN-γ in high-risk relatives even though it does not prevent type 1 diabetes
Journal of Interferon and Cytokine Research, 2006, 26(4), 207-213.
Web of Science® Times Cited: 13 |
F Wisloff, N Gulbrandsen, Maria Hjorth, S Lenhoff and P Fayers
Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changes
European Journal of Haematology, 2005, 75(4), 293-298.
Web of Science® Times Cited: 14 |
Conference Articles
Rosaura Casas, Maria Hjorth, Stina Axelsson, Mikael Chéramy, Mikael Pihl and Johnny Ludvigsson
Specific immunomodulatory effect of GAD(65) in type 1 diabetics
in DIABETOLOGIA, vol 52, 2009.
|
Maria Hjorth, Stina Axelsson, Johnny Ludvigsson and Rosaura Casas
GAD-alum treatment induces GAD-specific FOXP3+ cells in type 1 diabetic children
in DIABETOLOGIA, vol 52, 2009.
|
Stina Axelsson, Maria Hjorth, L Akerman, Johnny Ludvigsson and Rosaura Casas
Treatment with alum-formulated GAD65 in type 1 diabetic children results in early induction of Th2 responses
in DIABETOLOGIA, vol 52, 2009.
|
Ph.D. Theses
* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.
Ph.D., Lic. Theses
